0 Novel strategies on the horizon for pancreatic cancer: an interview with Philip A Philip
Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.
Topics
Biological and targeted therapies
Biomarkers
0 Nanocytology as a potential biomarker for cancer
Find out about how nanocytology may provide an entirely new platform for cancer detection and monitoring in this editorial from Biomarkers in Medicine.
Chemotherapy
0 Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance
This article outlines the importance of homologous recombination repair pathway in development of breast carcinoma (BC), and the influence of gene alterations in chemotherapy treated BC samples.
Clinical trials
0 Understanding sarcomas and other rare tumors: an interview with Robin Jones
Editor, Jade Parker recently spoke with world-renowned sarcoma expert, Robin L Jones. In this interview discover challenges in the diagnosis, treatment and clinical trials of sarcoma and other rare tumors.
Diagnostics
0 Nanocytology as a potential biomarker for cancer
Find out about how nanocytology may provide an entirely new platform for cancer detection and monitoring in this editorial from Biomarkers in Medicine.
Drug development
0 Spotlight on biosimilars in oncology: survey infographic
As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.
Epidemiology
0 Strong evidence for causal link between alcohol consumption and cancer development, finds study
A review of the latest epidemiological evidence strengthens a causal link between the consumption of alcohol and cancers at seven sites in the body.
Genetics
0 Sanger Institute series: uncovering the genetics of cancer – interview with Peter Campbell
Editor Jade Parker, speaks to Peter Campbell (Wellcome Trust Sanger Institute, Cambridge, UK) to find out how he is working towards identifying the preventable causes of cancer.
Immunotherapy
0 Immunotherapy for penile cancer
Find out about immunotherapeutic strategies for penile cancer, with a particular focus on the role of HPV as a potential target for immunotherapy in this commentary article.
Metastasis
0 Tumor location in metastatic colorectal cancer: predictive or prognostic?
Dr Hafez Halawani talks to Oncology Central regarding the predictive and prognostic potential of tumor location in metastatic colorectal cancer – a debate that was perpetuated with the presentation of the Venook et al study at the 2016 ASCO meeting.
Pathology and cancer biology
0 Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues
In this editorial from Future Oncology the different types of endometrial cancer are appraised.
Personalized medicine
0 Nanocytology as a potential biomarker for cancer
Find out about how nanocytology may provide an entirely new platform for cancer detection and monitoring in this editorial from Biomarkers in Medicine.
Prevention and screening
0 Opportunities for multiparametric MRI with PI-RADS v2 to make a difference
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.
Radiation oncology
0 Radioembolization for hepatocellular carcinoma: current role and future directions – the medical oncologist’s perspective
This article reviews yttrium-90 radioembolization of hepatocellular carcinoma from a clinical perspective, considering safety and efficacy, patient selection, and optimal assessment and management of patients.
Supportive oncology
0 NCRI 2018: Study highlights gaps in addressing the long-term consequences of cancer
Millions of people are living with the long-term consequences of cancer and its treatment, but currently there is very little research on the problems they face and how these can be tackled.
Surgical oncology
0 Interventional oncology and minimally invasive surgery – interview with Daniel Brown
As part of our spotlight we spoke with Daniel B Brown from the Vanderbilt Cancer Center (TN, USA) about his work in the field of interventional oncology and minimally invasive surgery.
